Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fulminant viral hepatitis

S C Pappas1

  • 1Department of Transplantation, Methodist Hospital of Indiana, Indianapolis 46202, USA.

Gastroenterology Clinics of North America
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Fulminant viral hepatitis, a severe complication of acute viral hepatitis, lacks effective treatments. Improved outcome prediction is crucial due to the increasing use of liver transplantation for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: hepatitis C virus (HCV) disease progression - HCV cure and the elimination of the "ethnic slope".

Alimentary pharmacology & therapeutics·2017
Same author

Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.

Alimentary pharmacology & therapeutics·2017
Same author

Preventing hepatitis B in health care workers.

Canadian family physician Medecin de famille canadien·2011
Same author

Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review.

Mayo Clinic proceedings·1997
Same author

Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?

Hepatology (Baltimore, Md.)·1996
Same author

New techniques for liver transplantation: reduced-size, split-liver, living-related and auxiliary liver transplantation.

Scandinavian journal of gastroenterology. Supplement·1995
Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026
Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026
Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026
Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026
Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026
See all related articles

Area of Science:

  • Hepatology
  • Virology
  • Transplantation Medicine

Background:

  • Fulminant viral hepatitis represents a critical and life-threatening complication of acute viral hepatitis.
  • Despite advancements in identifying causative viral agents, effective and specific therapeutic interventions remain limited.
  • The increasing application of liver transplantation highlights the urgent need for better prognostic indicators.

Purpose of the Study:

  • To review the current understanding of fulminant viral hepatitis.
  • To discuss the challenges in managing this severe condition.
  • To emphasize the importance of predicting patient outcomes.

Main Methods:

  • Literature review of viral hepatitis and fulminant hepatic failure.
  • Analysis of current treatment modalities, including liver transplantation.

Related Experiment Videos

  • Discussion of prognostic factors and outcome prediction strategies.

    • Main Results:

    • Fulminant viral hepatitis is associated with high mortality without timely intervention.
    • Liver transplantation has become a key therapeutic option, improving survival rates.
    • Accurate prediction of patient outcomes is essential for appropriate treatment allocation.

    Conclusions:

    • Effective, specific therapies for fulminant viral hepatitis are still needed.
    • Liver transplantation is a viable option but requires careful patient selection.
    • Enhanced methods for predicting outcomes are critical to optimize management and resource allocation.